INSMED Inc — Director's Dealing 2019

Nov 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2019-11-18

Reporting Person: GOLL JOHN (Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-18	Stock Option	M	25000	$12.58	Acquired	32322	Direct
2019-11-18	Stock Option	S	25000	$20.04	Disposed	7322	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-18	Stock Option (right to buy)	$12.58	M	25000	Acquired	2024-06-02	Common Stock (25000)	Direct

Footnotes

F1: This is the weighted average sales price representing 25,000 shares sold at prices ranging from $19.75 to $20.20 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F2: Stock options granted under the Company's 2013 Incentive Plan. These stock options are currently exercisable